Capsule Retention Inhaler for Rapid Aerosol Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing inhalers require complex user interactions and additional steps for loading a capsule, which can be challenging for patients, especially during acute medical conditions, and may prolong the delivery of pharmaceutically active ingredients.

Innovation Solution

An inhaler design with a pre-loaded capsule receptacle and a retention element that moves between positions to securely hold the capsule until use, allowing for quick activation and delivery of the active ingredient without additional assembly steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If the capsule is pre-loaded into the inhaler, then the time to deliver the pharmaceutically active ingredient is reduced, but the device complexity increases due to additional components like retention elements

Engineering Contradiction:
Improvetime to deliver pharmaceutically active ingredientVSAvoiddevice complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The capsule is pre-loaded into the inhaler during manufacturing, so that when the patient uses the inhaler, the capsule is already in position and ready for immediate aerosolization. This eliminates the need for the patient to perform the loading step, significantly reducing the time from capsule insertion to medication delivery.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

A retention element is introduced as an intermediary component between the capsule receptacle and the aerosolization chamber. This retention element selectively blocks the airflow path to prevent capsule migration during storage, and can be moved to allow capsule transfer during use. This intermediary mechanism enables pre-loading while maintaining device simplicity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If the retention element blocks the airflow path, then the capsule is prevented from moving prematurely, but the airflow path is obstructed

Engineering Contradiction:
Improvecapsule position stabilityVSAvoidairflow efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The retention element is designed to be movable rather than fixed. During storage, the retention element blocks the airflow path to stabilize capsule position. During use, the retention element can be moved (e.g., by actuator engagement) to open the airflow path, allowing the capsule to be transferred to the aerosolization chamber. This dynamic behavior resolves the contradiction between stability and airflow efficiency.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The inhaler simplifies the user experience by reducing the number of steps and ensuring rapid delivery of the medication, even in debilitating conditions, with a pre-loaded capsule that maintains orientation for efficient rupture and aerosolization.

Implementation Method 1

a retention element movable between a first position in which the capsule is prevented from moving from the capsule receptacle to the aerosolization chamber

Methodology Applied
Scientific EffectPhysical blockage:

Implementation Method 2

an aerosolization chamber for allowing the composition to be entrained in airflow within the airflow path

Methodology Applied
Scientific EffectAerosolization: Aerosol

Data Source

PatentUS20250295871A1An inhaler comprising a retention element
Publication Date: 2025.09.25 ASPEYA US INC
  • US20250295871A1 patent drawing
  • US20250295871A1 patent drawing
  • US20250295871A1 patent drawing

AI summary

An inhaler is provided, including: a housing defining an inlet, an outlet, and an airflow path extending from the inlet to the outlet; a capsule receptacle configured to receive a capsule including a composition for inhalation; a rupturing component configured to rupture the capsule received in the capsule receptacle; an aerosolization chamber configured to allow the composition to be entrained in airflow within the airflow path; and a retention component movable between a first position in which the capsule is prevented from moving from the capsule receptacle to the aerosolization chamber, and a second position in which the capsule is movable from the capsule receptacle to the aerosolization chamber, the retention component extending through the inlet when the retention element is in the first position.